Report cover image

Global Animal Model for Testing Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Dec 29, 2025
Length 191 Pages
SKU # APRC20785023

Description

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.

Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.

In our report, all the animals used in scientific purposes are included.

Global Animal Model for Testing key players include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, etc. Global top four manufacturers hold a share about 45%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share over 50 percent.

In terms of product, Mice is the largest segment, with a share over 60%. And in terms of application, the largest application is Pharmaceutical and Biotechnology Companies, followed by Academic and Research Institutes.

Report Includes

This report presents an overview of global market for Animal Model for Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Animal Model for Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Animal Model for Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Animal Model for Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Animal Model for Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Animal Model for Testing revenue, projected growth trends, production technology, application and end-user industry.


Animal Model for Testing Segment by Company

Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology

Animal Model for Testing Segment by Type

Rats
Mice
Others

Animal Model for Testing Segment by Application

Academic and Research Institutes
Pharmaceutical and Biotechnology Companies

Animal Model for Testing Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Model for Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Model for Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Model for Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Animal Model for Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Animal Model for Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Model for Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Animal Model for Testing Market by Type
1.2.1 Global Animal Model for Testing Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Rats
1.2.3 Mice
1.2.4 Others
1.3 Animal Model for Testing Market by Application
1.3.1 Global Animal Model for Testing Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Animal Model for Testing Market Dynamics
2.1 Animal Model for Testing Industry Trends
2.2 Animal Model for Testing Industry Drivers
2.3 Animal Model for Testing Industry Opportunities and Challenges
2.4 Animal Model for Testing Industry Restraints
3 Global Growth Perspective
3.1 Global Animal Model for Testing Market Perspective (2021-2032)
3.2 Global Animal Model for Testing Growth Trends by Region
3.2.1 Global Animal Model for Testing Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Animal Model for Testing Market Size by Region (2021-2026)
3.2.3 Global Animal Model for Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Animal Model for Testing Revenue by Players
4.1.1 Global Animal Model for Testing Revenue by Players (2021-2026)
4.1.2 Global Animal Model for Testing Revenue Market Share by Players (2021-2026)
4.1.3 Global Animal Model for Testing Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Animal Model for Testing Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Animal Model for Testing Key Players Headquarters & Area Served
4.4 Global Animal Model for Testing Players, Product Type & Application
4.5 Global Animal Model for Testing Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Animal Model for Testing Market CR5 and HHI
4.6.3 2025 Animal Model for Testing Tier 1, Tier 2, and Tier 3
5 Animal Model for Testing Market Size by Type
5.1 Global Animal Model for Testing Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Animal Model for Testing Revenue by Type (2021-2032)
5.3 Global Animal Model for Testing Revenue Market Share by Type (2021-2032)
6 Animal Model for Testing Market Size by Application
6.1 Global Animal Model for Testing Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Animal Model for Testing Revenue by Application (2021-2032)
6.3 Global Animal Model for Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 Charles River Laboratories
7.1.1 Charles River Laboratories Company Information
7.1.2 Charles River Laboratories Business Overview
7.1.3 Charles River Laboratories Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.1.4 Charles River Laboratories Animal Model for Testing Product Portfolio
7.1.5 Charles River Laboratories Recent Developments
7.2 Envigo
7.2.1 Envigo Company Information
7.2.2 Envigo Business Overview
7.2.3 Envigo Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.2.4 Envigo Animal Model for Testing Product Portfolio
7.2.5 Envigo Recent Developments
7.3 Taconic Biosciences
7.3.1 Taconic Biosciences Company Information
7.3.2 Taconic Biosciences Business Overview
7.3.3 Taconic Biosciences Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.3.4 Taconic Biosciences Animal Model for Testing Product Portfolio
7.3.5 Taconic Biosciences Recent Developments
7.4 Jackson Laboratory
7.4.1 Jackson Laboratory Company Information
7.4.2 Jackson Laboratory Business Overview
7.4.3 Jackson Laboratory Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.4.4 Jackson Laboratory Animal Model for Testing Product Portfolio
7.4.5 Jackson Laboratory Recent Developments
7.5 Crown Biosciences
7.5.1 Crown Biosciences Company Information
7.5.2 Crown Biosciences Business Overview
7.5.3 Crown Biosciences Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.5.4 Crown Biosciences Animal Model for Testing Product Portfolio
7.5.5 Crown Biosciences Recent Developments
7.6 Shanghai SLAC
7.6.1 Shanghai SLAC Company Information
7.6.2 Shanghai SLAC Business Overview
7.6.3 Shanghai SLAC Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.6.4 Shanghai SLAC Animal Model for Testing Product Portfolio
7.6.5 Shanghai SLAC Recent Developments
7.7 Shangghai Modelorg
7.7.1 Shangghai Modelorg Company Information
7.7.2 Shangghai Modelorg Business Overview
7.7.3 Shangghai Modelorg Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.7.4 Shangghai Modelorg Animal Model for Testing Product Portfolio
7.7.5 Shangghai Modelorg Recent Developments
7.8 GenOway
7.8.1 GenOway Company Information
7.8.2 GenOway Business Overview
7.8.3 GenOway Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.8.4 GenOway Animal Model for Testing Product Portfolio
7.8.5 GenOway Recent Developments
7.9 Syngene International
7.9.1 Syngene International Company Information
7.9.2 Syngene International Business Overview
7.9.3 Syngene International Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.9.4 Syngene International Animal Model for Testing Product Portfolio
7.9.5 Syngene International Recent Developments
7.10 Psychogenics
7.10.1 Psychogenics Company Information
7.10.2 Psychogenics Business Overview
7.10.3 Psychogenics Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.10.4 Psychogenics Animal Model for Testing Product Portfolio
7.10.5 Psychogenics Recent Developments
7.11 Pharmaron
7.11.1 Pharmaron Company Information
7.11.2 Pharmaron Business Overview
7.11.3 Pharmaron Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.11.4 Pharmaron Animal Model for Testing Product Portfolio
7.11.5 Pharmaron Recent Developments
7.12 Pharmalegacy
7.12.1 Pharmalegacy Company Information
7.12.2 Pharmalegacy Business Overview
7.12.3 Pharmalegacy Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.12.4 Pharmalegacy Animal Model for Testing Product Portfolio
7.12.5 Pharmalegacy Recent Developments
7.13 Vitalstar Biotechnology
7.13.1 Vitalstar Biotechnology Company Information
7.13.2 Vitalstar Biotechnology Business Overview
7.13.3 Vitalstar Biotechnology Animal Model for Testing Revenue and Gross Margin (2021-2026)
7.13.4 Vitalstar Biotechnology Animal Model for Testing Product Portfolio
7.13.5 Vitalstar Biotechnology Recent Developments
8 North America
8.1 North America Animal Model for Testing Revenue (2021-2032)
8.2 North America Animal Model for Testing Revenue by Type (2021-2032)
8.2.1 North America Animal Model for Testing Revenue by Type (2021-2026)
8.2.2 North America Animal Model for Testing Revenue by Type (2027-2032)
8.3 North America Animal Model for Testing Revenue Share by Type (2021-2032)
8.4 North America Animal Model for Testing Revenue by Application (2021-2032)
8.4.1 North America Animal Model for Testing Revenue by Application (2021-2026)
8.4.2 North America Animal Model for Testing Revenue by Application (2027-2032)
8.5 North America Animal Model for Testing Revenue Share by Application (2021-2032)
8.6 North America Animal Model for Testing Revenue by Country
8.6.1 North America Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Animal Model for Testing Revenue by Country (2021-2026)
8.6.3 North America Animal Model for Testing Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Animal Model for Testing Revenue (2021-2032)
9.2 Europe Animal Model for Testing Revenue by Type (2021-2032)
9.2.1 Europe Animal Model for Testing Revenue by Type (2021-2026)
9.2.2 Europe Animal Model for Testing Revenue by Type (2027-2032)
9.3 Europe Animal Model for Testing Revenue Share by Type (2021-2032)
9.4 Europe Animal Model for Testing Revenue by Application (2021-2032)
9.4.1 Europe Animal Model for Testing Revenue by Application (2021-2026)
9.4.2 Europe Animal Model for Testing Revenue by Application (2027-2032)
9.5 Europe Animal Model for Testing Revenue Share by Application (2021-2032)
9.6 Europe Animal Model for Testing Revenue by Country
9.6.1 Europe Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Animal Model for Testing Revenue by Country (2021-2026)
9.6.3 Europe Animal Model for Testing Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Animal Model for Testing Revenue (2021-2032)
10.2 China Animal Model for Testing Revenue by Type (2021-2032)
10.2.1 China Animal Model for Testing Revenue by Type (2021-2026)
10.2.2 China Animal Model for Testing Revenue by Type (2027-2032)
10.3 China Animal Model for Testing Revenue Share by Type (2021-2032)
10.4 China Animal Model for Testing Revenue by Application (2021-2032)
10.4.1 China Animal Model for Testing Revenue by Application (2021-2026)
10.4.2 China Animal Model for Testing Revenue by Application (2027-2032)
10.5 China Animal Model for Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Animal Model for Testing Revenue (2021-2032)
11.2 Asia Animal Model for Testing Revenue by Type (2021-2032)
11.2.1 Asia Animal Model for Testing Revenue by Type (2021-2026)
11.2.2 Asia Animal Model for Testing Revenue by Type (2027-2032)
11.3 Asia Animal Model for Testing Revenue Share by Type (2021-2032)
11.4 Asia Animal Model for Testing Revenue by Application (2021-2032)
11.4.1 Asia Animal Model for Testing Revenue by Application (2021-2026)
11.4.2 Asia Animal Model for Testing Revenue by Application (2027-2032)
11.5 Asia Animal Model for Testing Revenue Share by Application (2021-2032)
11.6 Asia Animal Model for Testing Revenue by Country
11.6.1 Asia Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Animal Model for Testing Revenue by Country (2021-2026)
11.6.3 Asia Animal Model for Testing Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Animal Model for Testing Revenue (2021-2032)
12.2 SAMEA Animal Model for Testing Revenue by Type (2021-2032)
12.2.1 SAMEA Animal Model for Testing Revenue by Type (2021-2026)
12.2.2 SAMEA Animal Model for Testing Revenue by Type (2027-2032)
12.3 SAMEA Animal Model for Testing Revenue Share by Type (2021-2032)
12.4 SAMEA Animal Model for Testing Revenue by Application (2021-2032)
12.4.1 SAMEA Animal Model for Testing Revenue by Application (2021-2026)
12.4.2 SAMEA Animal Model for Testing Revenue by Application (2027-2032)
12.5 SAMEA Animal Model for Testing Revenue Share by Application (2021-2032)
12.6 SAMEA Animal Model for Testing Revenue by Country
12.6.1 SAMEA Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Animal Model for Testing Revenue by Country (2021-2026)
12.6.3 SAMEA Animal Model for Testing Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.